Health News Releases

  • Today April 13
June 13, 2013 15:10
Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with Lead Product NBTXR3
NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that its lead compound NBTXR3 has received authorizati
June 13, 2013 09:28
IncellDx Signs Deal With Kindstar Global to Offer Novel HPV Technology in China for Cervical Cancer Screening
IncellDx announced today that it has executed an agreement with Kindstar Global, the largest esoteric diagnostic testing service in China, to offer its proprietary laboratory test for the detection of
June 12, 2013 09:32
CanChew Biotechnologies Shipping Large-Scale Product Orders -- Expands Into Wholesale and Distributor Sales of Its CanChew CBD Gum
CanChew Biotechnologies, a Medical Marijuana Inc. (OTC:MJNA) joint venture company, is excited to announce its wholly owned subsidiary CannaGum Marketing Group has opened a new warehouse for CanChew C
June 11, 2013 17:46
Harmony(TM) Prenatal Test Demonstrates Clinical Utility in a General Screening Population
The Harris Birthright Centre for Fetal Medicine today released results from a clinical implementation study (http://onlinelibrary.wiley.com/doi/10.1002/uog.12504/full) on the use of Ariosa Diagnostics
June 04, 2013 15:10
Nanobiotix's NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma
NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces positive Phase I interim results of its lead nanoparticle-ba
June 03, 2013 14:45
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Primary end-point results from the BIOFLOW-II Clinical Study demonstrating the non-inferiority of the BIOTRONIK Orsiro Hybrid Drug-Eluting Stent compared to Abbott's XIENCE PRIME™. These results were
May 24, 2013 14:08
BIOTRONIK Announces Completion of Enrollment in IMPACT Study to Investigate Stroke Risk Reduction in Patients With Atrial Fibrillation
BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed for the highly anticipated IMPACT study. The study aims to investigate whether th
May 21, 2013 23:00
Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Late-Breaking Abstract Session During Digestive Disease Week 2013
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat patients with gastrointestinal disorders and diseases, today presented positive safety and efficacy results from its large
May 16, 2013 22:00
Medical Marijuana Inc., Posts 1st Quarter Audited Financial and Disclosure Statements; Net Income Exceeds Quarterly Projections
Medical Marijuana Inc. (OTC:MJNA) is pleased to inform shareholders that it has completed and posted its 1st Quarter 2013 Audited Financial Statements and Corporate Disclosure. The disclosure can be f
May 15, 2013 18:29
Invivoscribe Prevails in German District Court (FLT3 Patent Infringement Action)
MLL Münchner Leukämielabor GmbH (“MLL”) Laboratories has been found guilty of patent infringement in a matter involving FLT3 testing patent rights licensed exclusively to Invivoscribe Technologies, In
May 15, 2013 09:52
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for addition to the NASDAQ Biotechnolog
Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results
May 10, 2013 09:43
Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the first quarter en
May 09, 2013 10:53
EasyMed Reports Publication of Results of a Large-Scale Trial With the University Hospital of Geneva in the Peer-Reviewed Journal BMC Health Service Research
EasyMed Services Inc. (CNSX:EZM)(PINKSHEETS:EMYSF)(MUN:EY6) (“EasyMed” or the “Company”) announces that the report of a large-scale study conducted by the University Hospital of Geneva, using EasyMed'
May 02, 2013 18:00
GlobalMed, International Virtual e-Hospital Foundation, and ITF Entering Phase II of Telemedicine Implementation in Cape Verde
GlobalMed®—the worldwide leader in real-time healthcare delivery systems—along with the International Trust Fund Enhancing Human Security (ITF), a non-profit organization founded by the Republic of Sl
April 22, 2013 12:00
Medical Marijuana Inc.'s Dixie Botanicals Brand Announces New Exciting Products and a Consumer Friendly Mobile App
Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator, announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Botanicals is rolling out three new exciting offerings.
April 17, 2013 09:59
Medical Marijuana Inc.'s Dixie Elixirs Brand to Co-Sponsor Premiere of Snoop Lion Movie “Reincarnated” During 4/20 Week
Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator, announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Elixirs and Edibles, has completed negotiations with The
April 17, 2013 09:48
Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock
Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering of 16,375,000 shares of
April 12, 2013 22:00
Medical Marijuana Inc. Reports Record First Quarter 2013 Revenue and Income
Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and hemp industry innovator, today is pleased to pre-announce its fourth quarter earnings. The company earned net income of approximately $5.52 m
April 11, 2013 10:05
Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of Common Stock
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced the pricing of an underwritten public offering of 16,375,000 shar
April 10, 2013 09:54
Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it is offering to sell an aggregate value of $90,000,000 of
March 21, 2013 16:07
N.Y. Times Best-Selling Author to Highlight 6th World Medical Tourism Congress
The Medical Tourism Association™ released today a preliminary line-up of speakers who will address up to 2,000 participants from over 90 countries during the 6th World Medical Tourism & Global Healthc
DIMEDI Attends KIMES 2013, Will Exhibit Upgraded ‘X-ray Film Scanner’
March 11, 2013 10:29
DIMEDI Attends KIMES 2013, Will Exhibit Upgraded ‘X-ray Film Scanner’
Professional medical devices company, DIMEDI Co., Ltd (CEO Nam Yun, www.demedi.co.kr), revealed that it will be attending the upcoming 29th KIMES (Korea International Medical + Hospital Equipment Show
March 08, 2013 15:05
BioLegend Receives ISO 9001:2008 and ISO 13485:2003 Certification
BioLegend in San Diego, CA, a leading provider of antibodies and reagents for biomedical research, has been granted ISO 9001:2008 certification for manufacturing and distribution of antibodies, protei
March 08, 2013 09:06
Vital Images, Inc. Receives 510(k) Clearance From the U.S. Food and Drug Administration for Its CT TAVR Planning Application
Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, received 510(k) clearance from the United St
February 27, 2013 08:26
New Report Recommends Public Health Focus on Harmful Drinking vs. Eliminating Consumption
The traditional public health perspective on alcohol and noncommunicable diseases is indicted in a new report from the International Center for Alcohol Policies (ICAP). “Alcohol misuse and global heal
25 per page50 per page75 per page100 per page